BOOGIE XPRO Словакия - словашки - myHealthbox

boogie xpro

bayer ag - emulgovateľný koncentrát - bixafen 50 g/l; prothioconazole 100 g/l; spiroxamin 250 g/l

BOOGIE XPRO Словакия - словашки - myHealthbox

boogie xpro

bayer ag - emulgovateľný koncentrát - bixafen 50 g/l; prothioconazole 100 g/l; spiroxamin 250 g/l

INPUT Словакия - словашки - myHealthbox

input

bayer ag - emulzný koncentrát - prothioconazole 160 g/l; spiroxamine 300 g/l

INPUT Словакия - словашки - myHealthbox

input

bayer ag - emulzný koncentrát - prothioconazole 160 g/l; spiroxamine 300 g/l

Aknemycin Словакия - словашки - ŠÚKL (Štátny ústav pre kontrolu liečiv)

aknemycin

almirall hermal gmbh, nemecko - erytromycín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)

Aknemycin Plus Словакия - словашки - ŠÚKL (Štátny ústav pre kontrolu liečiv)

aknemycin plus

almirall hermal gmbh, nemecko - erytromycín, kombinácie - 46 - dermatologica

Methylthioninium chloride Proveblue Европейски съюз - словашки - EMA (European Medicines Agency)

methylthioninium chloride proveblue

provepharm sas - metyltioníniumchlorid - methemoglobinémiu - všetky ostatné terapeutické produkty - akútna symptomatická liečba methemoglobinémie vyvolanej liečivami a chemickými výrobkami. methylthioninium chloride proveblue je indikovaný u dospelých, detí a dospievajúcich (vo veku 0-17 rokov).

Zydelig Европейски съюз - словашки - EMA (European Medicines Agency)

zydelig

gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.